2019
DOI: 10.1371/journal.pone.0213673
|View full text |Cite
|
Sign up to set email alerts
|

Senescence-associated-β-galactosidase staining following traumatic brain injury in the mouse cerebrum

Abstract: Primary and secondary traumatic brain injury (TBI) can cause tissue damage by inducing cell death pathways including apoptosis, necroptosis, and autophagy. However, similar pathways can also lead to senescence. Senescent cells secrete senescence-associated secretory phenotype proteins following persistent DNA damage response signaling, leading to cell disorders. TBI initially activates the cell cycle followed by the subsequent triggering of senescence. This study aims to clarify how the mRNA and protein expres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
47
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(51 citation statements)
references
References 37 publications
4
47
0
Order By: Relevance
“…Because TBI increases senescence-associated β-gal activity at pH 6.0 (Tominaga et al, 2019), we performed X-gal staining at pH 7.4 in the TBI-induced brain of the wild-type mice. No X-gal staining was observed in the TBI-induced brain of the wild-type mouse, indicating no senescence-associated β-gal activity in this assay system.…”
Section: Resultsmentioning
confidence: 99%
“…Because TBI increases senescence-associated β-gal activity at pH 6.0 (Tominaga et al, 2019), we performed X-gal staining at pH 7.4 in the TBI-induced brain of the wild-type mice. No X-gal staining was observed in the TBI-induced brain of the wild-type mouse, indicating no senescence-associated β-gal activity in this assay system.…”
Section: Resultsmentioning
confidence: 99%
“…The role of senescent cells in cognitive decline and p-tau pathology has been demonstrated in a transgenic mouse model of AD, in which eliminating senescent cells through senolytic intervention resulted in reduced tau phosphorylation, improved cognitive outcomes, and the prevention of the upregulation of senescence genes [14]. In the context of TBI, markers of senescence have been shown to elevate in microglia and astrocytes following a controlled cortical impact protocol [153]. Contrary to studies showing vascular dysfunction in mTBI [2, 157], we did not see evidence of cellular senescence in endothelial cells.…”
Section: Discussionmentioning
confidence: 99%
“…The accumulation of senescent cells in the brain is thought to drive ageing and age-related diseases [155], cognitive decline [6], and neurodegenerative pathology [81]. More recently, markers of senescence were shown to be elevated in a mouse model of mTBI [153] and, in our previous work, we have shown evidence of DNA damage in human cases with a history of acute and chronic mTBI [135].…”
Section: Introductionmentioning
confidence: 89%
“…Pharmacological inhibitors of cell cycle flavopiridol, roscovitine and olomoucine were observed to suppress DNA damaging agent, etoposide-induced apoptosis in rat primary cortical neurons [ 114 ]. Wide-spread cell cycle stimulation and associated neuronal death was observed in rat brains subjected to traumatic injury [ 185 , 186 ]. Flavopiridol treatment interestingly, could attenuate cyclin D1 expression and consequently cell cycle activation in neurons and glia in brains of these animals.…”
Section: Cell Cycle Machinery Targeting Compounds As Neuroprotective mentioning
confidence: 99%